Revance Therapeutics | 营业费用

Name: Revance Therapeutics | 营业费用
Creator: TRADING ECONOMICS
License: https://creativecommons.org/licenses/by/4.0/

	Operating Expenses	更改		日
Supernus Pharmaceuticals	USD 165.31M		19.57M	2023-12

Revance Therapeutics 营业费用 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2024.